Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
CA 2362830 C · Owner: Underwood, Lowell J. · Inventors: O'Brien, Timothy J.; Underwood, Lowell J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a TADG-12 protein and a DNA fragment encoding such protein. Also provided is a vector/host cell capable of expressing the DNA. The present invention further provided various methods of early detection of associated ovarian and other malignancies and of interactive therapies for , cancer treatment by utilizing the DNA and/or protein disclosed herein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 2, 2000 and granted August 21, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.